Ref: Syn/CS/SE/PR/May 2018 Syngene International Limited Biocon SEZ, Biocon Park, Plot No. 2 & 3, Bommasandra Industrial Area, IV Phase, Jigani Link Road, Bengaluru 560099, India T +91 80 6775 8000 F +91 80 6775 8808 CIN: L85110KA1993PLC014937 www.syngeneintl.com May 30, 2018 To, To, The Manager Listing The Manager Listing BSE Limited National Stock Exchange of India Limited Corporate Relationship Department Corporate Communication Department Dalal Street, Mumbai – 400 001 Bandra (EAST), Mumbai – 400 051 Scrip Code: 539268 Scrip Symbol: SYNGENE Dear Sir/Madam, Subject: Press Release This has reference to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, Please find enclosed the press release titled “Syngene International Announces Partnership with Zumutor Biologics for Biotherapeutic Antibody Discovery Services ”. The above mentioned press release will also be available on website of the Company www.syngeneintl.com. This is for your information and records. Thanking You, Yours faithfully, For SYNGENE INTERNATIONAL LIMITED ____________ Mayank Verma Company Secretary
3
Embed
Subject: Press Release Syngene International Announces ... · Commenting on the collaboratio n, Dr. Manoj Nerurkar, Chief Operating Officer, Syngene International , said, " Syngene
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Ref: Syn/CS/SE/PR/May 2018 Syngene International Limited
Biocon SEZ, Biocon Park, Plot No. 2 & 3,
Bommasandra Industrial Area, IV Phase,
Jigani Link Road, Bengaluru 560099, India
T +91 80 6775 8000
F +91 80 6775 8808
CIN: L85110KA1993PLC014937 www.syngeneintl.com
May 30, 2018
To, To,
The Manager Listing The Manager Listing
BSE Limited National Stock Exchange of India Limited
Corporate Relationship Department Corporate Communication Department